Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles B Davis

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Occupational and Environmental Hygiene|February 4, 2015
"Quasi nonparametric" upper tolerance limits for occupational exposure evaluationsCharles B Davis, Paul F Wambach
Clinical and Translational Science|October 13, 2020
Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency-Guided First-in-Human StudiesMatthew J Goldstein, Malte Peters, Barbara L Weber, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 10, 2008
Impact of erythrocyte Duffy antigen genetic polymorphism on the distribution of GroBeta-T, a novel human CXC chemokineTimothy W Hepburn, LeeAnn P Tobia, Wei Shi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 11, 2009
Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptidesTian Lan, Anuradha Rao, Jamie Haywood, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2008
Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the ratEric Garver, Erin D Hugger, Shawn P Shearn, et al.
Bioconjugate Chemistry|May 22, 2013
Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistryBrian M Zeglis, Charles B Davis, Robert Aggeler, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humansFung-Sing Chow, Lisa J Benincosa, Sunita B Sheth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2008
Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferretElisabeth Minthorn, Thomas Mencken, Andrew G King, et al.
Journal of Pharmaceutical Sciences|August 8, 2006
Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitorHong Xiang, Jeanelle McSurdy-Freed, Ganesh S Moorthy, et al.
Bioconjugate Chemistry|November 25, 2014
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imagingBrian M Zeglis, Charles B Davis, Dalya Abdel-Atti, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Occupational and Environmental Hygiene|February 4, 2015
"Quasi nonparametric" upper tolerance limits for occupational exposure evaluationsCharles B Davis, Paul F Wambach
Clinical and Translational Science|October 13, 2020
Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency-Guided First-in-Human StudiesMatthew J Goldstein, Malte Peters, Barbara L Weber, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 10, 2008
Impact of erythrocyte Duffy antigen genetic polymorphism on the distribution of GroBeta-T, a novel human CXC chemokineTimothy W Hepburn, LeeAnn P Tobia, Wei Shi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 11, 2009
Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptidesTian Lan, Anuradha Rao, Jamie Haywood, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2008
Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the ratEric Garver, Erin D Hugger, Shawn P Shearn, et al.
Bioconjugate Chemistry|May 22, 2013
Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistryBrian M Zeglis, Charles B Davis, Robert Aggeler, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humansFung-Sing Chow, Lisa J Benincosa, Sunita B Sheth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2008
Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferretElisabeth Minthorn, Thomas Mencken, Andrew G King, et al.
Journal of Pharmaceutical Sciences|August 8, 2006
Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitorHong Xiang, Jeanelle McSurdy-Freed, Ganesh S Moorthy, et al.
Bioconjugate Chemistry|November 25, 2014
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imagingBrian M Zeglis, Charles B Davis, Dalya Abdel-Atti, et al.
Pageof 2